Welcome to our dedicated page for OptimizeRx Corporation news (Ticker: OPRX), a resource for investors and traders seeking the latest updates and insights on OptimizeRx Corporation stock.
OptimizeRx Corporation (NASDAQ: OPRX) is a leading provider in the healthcare technology sector, offering digital health messaging solutions that enhance communication between pharmaceutical companies, healthcare providers, and patients. OptimizeRx specializes in the integration of electronic health records (EHR) to distribute financial assistance, educational materials, and clinical information directly at the point of care.
The company leverages its proprietary SampleMD and eCoupon technologies to expand the distribution of patient savings and support materials within the e-prescribing workflows of over 300,000 healthcare providers. These platforms enable healthcare providers to deliver real-time financial assistance and support to patients, thereby improving medication adherence and affordability.
OptimizeRx offers a range of products, including Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. These solutions aim to help patients start and stay on their prescribed treatments while providing pharmaceutical companies with efficient ways to increase brand awareness and adherence.
Recently, OptimizeRx has undergone significant leadership changes. Gus Halas retired as Chairperson of the Board, succeeded by Lynn O’Connor Vos, a seasoned executive with extensive experience in healthcare IT and life sciences. Additionally, Catherine M. Klema was appointed to the Board, bringing her expertise in strategy, finance, and governance.
Financially, OptimizeRx is in a robust position. The company's revenue for FY2023 is estimated to exceed $68-$70 million, with adjusted EBITDA ranging between $3-$4 million. For 2024, the company anticipates revenue of at least $100 million due to a revised gross-to-net accounting treatment for certain revenue streams from its recent acquisition of Medicx Health.
The mission of OptimizeRx is to empower the healthcare community through innovative, tech-enabled communication solutions that improve patient care. By connecting over 60% of U.S. healthcare providers and millions of patients through its digital point-of-care network, OptimizeRx continues to deliver significant value to patients, healthcare professionals, and investors.
For more information, visit www.optimizerx.com
OptimizeRx Corp (Nasdaq: OPRX) will hold a conference call on May 10, 2023, at 4:30 p.m. Eastern Time to discuss its first-quarter results for the period ending March 31, 2023. The financial results will be released prior to the call. Interested parties can join via a toll-free number at 1-888-886-7786 or internationally at 1-416-764-8658, using conference ID 54210852. The call will also be accessible through a webcast. A replay will be available for 12 months on OptimizeRx’s investor website. OptimizeRx focuses on providing technology solutions that improve patient engagement and ensure adherence to therapies.
OptimizeRx (Nasdaq: OPRX) has announced a share repurchase program, allowing for the buyback of up to $15 million of its common stock. The Board of Directors unanimously approved this decision, reflecting the company's solid working capital and belief that its shares are undervalued. CEO Will Febbo highlighted the long-term confidence in OptimizeRx's business, emphasizing the scalability offered by its extensive point-of-care network, which connects over 60% of U.S. healthcare providers.
FAQ
What is the current stock price of OptimizeRx Corporation (OPRX)?
What is the market cap of OptimizeRx Corporation (OPRX)?
What does OptimizeRx Corporation do?
What are the main products offered by OptimizeRx?
How does OptimizeRx help patients?
Who is the current Chairperson of OptimizeRx?
What recent changes have occurred in OptimizeRx's leadership?
What are OptimizeRx's financial expectations for 2024?
How widely is OptimizeRx's technology adopted?
What is SampleMD?
Where can I find more information about OptimizeRx?
What is the mission of OptimizeRx?
